Adherence rates and outcomes for 17-hydroxyprogesterone caproate use in women with a previous history of preterm birth.

Edwards, Alexandra M; Lowry, Sarah A; Mikovich, Sam; Forinash, Alicia B; Babbar, Shilpa

Edwards, Alexandra M; Lowry, Sarah A; Mikovich, Sam; Forinash, Alicia B; Babbar, Shilpa.

Afiliación

Edwards AM; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Saint Louis University School of Medicine, Saint Louis, MO. Electronic address: Alexandra.edwards@health.slu.edu.
Lowry SA; St. Louis College of Pharmacy, Saint Louis, MO.
Mikovich S; Confluence Health-Wenatchee Valley Hospital and Clinics, Wenatchee, WA.
Forinash AB; St. Louis College of Pharmacy, Saint Louis, MO.
Babbar S; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Children's Mercy Hospital, University of Missouri-Kansas City, Kansas City, MO.

Am J Obstet Gynecol MFM ; 2(3): 100166, 2020 08.

Article en En | MEDLINE | ID: mdl-33345885

Asunto(s)

Nacimiento Prematuro; Caproato de 17 alfa-Hidroxiprogesterona; 17-alfa-Hidroxiprogesterona; Adulto; Femenino; Humanos; Hidroxiprogesteronas/uso terapéutico; Lactante; Recién Nacido; Embarazo; Nacimiento Prematuro/tratamiento farmacológico; Estudios Retrospectivos; Estados Unidos/epidemiología

Palabras clave

17-hydroxyprogesterone caproate; 17OHPC; Makena; adherence; preterm birth; recurrent preterm birth; urban

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nacimiento Prematuro Tipo de estudio: Observational_studies Límite: Adult / Female / Humans / Infant / Newborn / Pregnancy País/Región como asunto: America do norte Idioma: En Revista: Am J Obstet Gynecol MFM Año: 2020 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google